Literature DB >> 21995283

Induction of chromosomal aberrations by carbon nanotubes and titanium dioxide nanoparticles in human lymphocytes in vitro.

Julia Catalán1, Hilkka Järventaus, Minnamari Vippola, Kai Savolainen, Hannu Norppa.   

Abstract

We examined if three commercially available nanomaterials - short singlewall carbon nanotubes (SWCNTs), short multiwall carbon nanotubes (MWCNTs) and nanosized titanium dioxide anatase (TiO(2); primary particle size <25 nm) - can induce structural chromosomal aberrations (CAs) in cultures of isolated human lymphocytes. To find a suitable sampling time, the cells were treated with 6.25-300 μg/ml of the nanomaterials for 24, 48 and 72 h. The 48-h treatment was the most effective, inducing a dose-dependent increase in chromosome-type CAs (all materials) and chromatid-type CAs (SWCNTs and TiO(2) anatase). The 72-h treatment yielded a positive result with SWCNTs. None of the treatments significantly affected cell count or the mitotic index. Our results suggest that with nanomaterials a continuous treatment for about two cell cycles is needed for CA induction, possibly reflecting access of nanomaterials to the nucleus during the first mitosis or delayed secondary genotoxic effect associated with the inflammatory process.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21995283     DOI: 10.3109/17435390.2011.625130

Source DB:  PubMed          Journal:  Nanotoxicology        ISSN: 1743-5390            Impact factor:   5.913


  4 in total

Review 1.  Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans.

Authors:  Eileen D Kuempel; Marie-Claude Jaurand; Peter Møller; Yasuo Morimoto; Norihiro Kobayashi; Kent E Pinkerton; Linda M Sargent; Roel C H Vermeulen; Bice Fubini; Agnes B Kane
Journal:  Crit Rev Toxicol       Date:  2016-08-18       Impact factor: 5.635

2.  Titanium dioxide nanoparticles: an in vitro study of DNA binding, chromosome aberration assay, and comet assay.

Authors:  Suhani Patel; Palak Patel; Sonal R Bakshi
Journal:  Cytotechnology       Date:  2017-01-03       Impact factor: 2.058

3.  Hazard Screening Methods for Nanomaterials: A Comparative Study.

Authors:  Barry Sheehan; Finbarr Murphy; Martin Mullins; Irini Furxhi; Anna L Costa; Felice C Simeone; Paride Mantecca
Journal:  Int J Mol Sci       Date:  2018-02-25       Impact factor: 5.923

Review 4.  A systematic quality evaluation and review of nanomaterial genotoxicity studies: a regulatory perspective.

Authors:  Kirsi K Siivola; Michael J Burgum; Blanca Suárez-Merino; Martin J D Clift; Shareen H Doak; Julia Catalán
Journal:  Part Fibre Toxicol       Date:  2022-09-14       Impact factor: 9.112

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.